Viewing Study NCT01397734

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:29 AM
Ignite Modification Date: 2026-02-24 @ 8:25 AM
Study NCT ID: NCT01397734
Status: TERMINATED
Last Update Posted: 2018-09-06
First Post: 2011-07-18
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Arsenic Trioxide and Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia (CML)
Sponsor: Beth Israel Deaconess Medical Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Myelogenous Leukemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None CML View
None Chronic myelogenous leukemia View
None Chronic Myeloid leukemia View
None Arsenic View
None Arsenic trioxide View
None Imatinib View
None Dasatinib View
None Nilotinib View
None TKI View
None Tyrosine kinase inhibitor View